Also from this source

Apr 24, 2018, 08:00 ET ASX/NASDAQ Announcement


You just read:

Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy

News provided by

Benitec Biopharma Limited

Jan 17, 2017, 05:00 ET